Getigan, Joser S.

HRN: 28-10-94  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2025
CEFTRIAXONE 1G (VIAL)
12/16/2025
12/22/2025
IV
2 Grams
OD
For Wound Debridement
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bone & JointSkin & Soft TissueProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: